GENEVA, Oct. 15 -- AIMED BIO INC. filed a patent application (KR2026/005239) for “ANTI-ROR1 ANTIBODY-DRUG CONJUGATE AND USE THEREOF”. With publication no. WO/2026/216855, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/68
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....